DUBLIN--(BUSINESS WIRE)--Research and Markets has announced the addition of the "Transfection Reagents and Equipment Market by Method (Biochemical (Calcium Phosphate, Lipofection, Dendrimers), Physical (Electroporation, Nucleofection), Viral)), Application (Biomedical, Protein Production), End User - Global Forecast to 2021" report to their offering.
The global transfection reagents market is expected to reach USD 1.02 Billion by 2021 from USD 715.4 Million in 2016, at a CAGR of 7.5% during the forecast period.
The key factors driving the growth of this market are technology advancements in transfections, global alliances among leading research institutes to trigger drug discovery, increase in R&D spending and research activities by pharmaceutical and biotechnology companies, increase in demand for synthetic genes, and rising incidence of cancer.
On the other hand, factors such as selective effectiveness of transfection reagents, home brew reagents by researchers, and high cost of transfection reagents are expected to limit the growth of the market.
The global transfection reagents market is segmented on the basis of product, method, application, end user, and region. On the basis of product, the market is segmented into reagents and instruments. In 2016, the reagents segment is estimated to account for the largest share of the market. However, the instruments segment is expected to grow at the highest CAGR during the forecast period.
Technological Advancements in Transfection Technology
- - Crispr-Cas9
- - Car-T
- - Three Dimension (3D) Transfection Technology
- Global Alliances Among Leading Research Institutes to Trigger Drug Discovery
- Increase in R&D Spending and Research Activities By Pharmaceutical and Biotech Companies
- Growing Research Activities in Cell Science
- Increase in Demand for Synthetic Genes
- Rising Incidence of Cancer Worldwide
- Selective Effectiveness of Transfection Reagents
- Home Brew Reagents Restrict Sale of Commercial Kits
- High Cost of Transfection Reagents
- Large-Scale Transfections
- High-Growth Opportunities in Asian Market
- - India
- - China
- Transfection in Hard-To-Transfect Cells
- Cytotoxicity in Transfection - A Major Concern
- Bio-Rad Laboratories, Inc.
- F. Hoffmann-La Roche Ltd
- Lonza Group Ltd.
- Maxcyte, Inc.
- Merck KGaA
- Mirus Bio LLC.
- Polyplus-Transfection Sa (Subsidary of Archimed)
- Promega Corporation
- Qiagen N.V.
- Thermo Fisher Scientific Inc. (Life Technologies)
For more information about this report visit http://www.researchandmarkets.com/research/rrbmjc/transfection